Andre Hoffmann, vice-chairman of Roche, on healthcare

Healthcare reform today is being avidly discussed in political, social, medical and business circles around the world. In developing countries, the billions of dollars spent on containing the spread of HIV/AIDS and other pandemic diseases such as TB and malaria, are beginning to show some positive results. In Europe, the cost of government-sponsored healthcare is having a negative impact on GDP, while in the US, the Obama Administration is embarking on the country's most ambitious attempt at providing universal coverage for some 47 million plus people in the country without health insurance.